NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 11th. Investors of record on Wednesday, July 25th will be given a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date of this dividend is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, August, 8th. The pharmacy operator reported $1.69 EPS for the quarter, topping analysts' consensus estimates of $1.61 by $0.08. The pharmacy operator earned $46.71 billion during the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The firm's revenue was up 2.2% on a year-over-year basis. During the same period last year, the business posted $1.33 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Wednesday, August, 8th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.00. CVS Health also updated its Q3 guidance to $1.68-1.73 EPS.

17 brokers have issued twelve-month price targets for CVS Health's shares. Their forecasts range from $68.00 to $101.00. On average, they expect CVS Health's stock price to reach $87.5333 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

CVS Health saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 51,997,306 shares, an increase of 3.8% from the August 15th total of 50,091,896 shares. Based on an average daily volume of 5,496,353 shares, the days-to-cover ratio is presently 9.5 days. Currently, 5.1% of the shares of the stock are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), FMR LLC (2.83%), Parnassus Investments CA (1.64%), Northern Trust Corp (1.48%), Bank of New York Mellon Corp (1.24%) and Bank of New York Mellon Corp (1.24%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of America Corp DE, Bank of Montreal Can, Massachusetts Financial Services Co. MA, Canada Pension Plan Investment Board, Standard Life Aberdeen plc, American Century Companies Inc. and NN Investment Partners Holdings N.V.. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Charles Schwab Investment Advisory Inc., Boston Partners, Morgan Stanley, Caisse DE Depot ET Placement DU Quebec, Bank of New York Mellon Corp, Bank of New York Mellon Corp and Fiera Capital Corp. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $78.74.

CVS Health has a market capitalization of $81.03 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]